| Source: |
| Type: |
| Cognitive |
| 3588- | CUR, | The effect of curcumin on cognition in Alzheimer’s disease and healthy aging: A systematic review of pre-clinical and clinical studies |
| - | Review, | AD, | NA |
| 3581- | CUR, | Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer's Disease |
| - | NA, | AD, | NA |
| 3577- | CUR, | Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study |
| - | Trial, | AD, | NA |
| 3576- | CUR, | Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease |
| - | Review, | AD, | NA |
| 3574- | CUR, | The effect of curcumin (turmeric) on Alzheimer's disease: An overview |
| - | Review, | AD, | NA |
| 6663- | DFE, | Nutraceuticals of Phoenix dactylifera L.: Physicochemistry, Nutritional Value and Therapeutic Potential |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 6754- | DHA, | Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial |
| - | Trial, | AD, | NA |
| 6756- | DHA, | Omega-3 Fatty Acids and Cognitive Function |
| - | Review, | AD, | NA |
| 4178- | DHA, | The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma |
| - | in-vivo, | NA, | NA |
| 4177- | DHA, | Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats |
| - | in-vivo, | NA, | NA |
| 6716- | dietF, | Current Research in Fermented Foods: Bridging Tradition and Science |
| - | Review, | Nor, | NA |
| 2272- | dietMet, | Methionine restriction - Association with redox homeostasis and implications on aging and diseases |
| - | Review, | Nor, | NA |
| 5071- | dietSTF, | Unraveling the impact of intermittent fasting in cancer prevention, mitigation, and treatment: A narrative review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 3708- | dietSTF, | Fasting as a Therapy in Neurological Disease |
| 3709- | dietSTF, | Intermittent Fasting Protects against Alzheimer’s Disease Possible through Restoring Aquaporin-4 Polarity |
| - | in-vitro, | AD, | NA |
| - | Human, | MS, | NA | - | NA, | IBD, | NA |
| 4254- | EA, | Chronic administration of ellagic acid improved the cognition in middle-aged overweight men |
| - | Human, | Obesity, | NA |
| 7209- | EGb 761, | Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review |
| - | Review, | AD, | NA |
| 7203- | EGb 761, | Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials |
| - | Review, | AD, | NA |
| 7202- | EGb 761, | Ginkgo biloba leaf extract EGb 761® for the treatment of various diseases: Overview of systematic reviews |
| - | Review, | AD, | NA |
| 7200- | EGb 761, | PCA, | Optimized Ginkgo biloba extract EGb 761®: boosted therapeutic benefits with minimized CYP enzyme interference |
| 7196- | EGb 761, | Ginkgo biloba extract EGb 761 in patients with dementia and a history of cerebral infarction-meta-analysis of pooled data from randomised clinical trials |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 7225- | EGb 761, | Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial |
| - | Trial, | AD, | NA |
| 7232- | EGb 761, | Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial |
| - | Trial, | AD, | NA |
| 7231- | EGb 761, | Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials |
| - | Review, | AD, | NA |
| 7239- | EGb 761, | Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis |
| - | Review, | AD, | NA |
| 7222- | EGb 761, | Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use |
| - | Review, | AD, | NA |
| 3232- | EGCG, | (−)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer׳s disease model mice by upregulating neprilysin expression |
| - | in-vivo, | AD, | NA |
| 3237- | EGCG, | (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression |
| - | in-vivo, | AD, | NA |
| 3593- | EGCG, | Epigallocatechin Gallate (EGCG) |
| - | Review, | AD, | NA |
| 6777- | EGCG, | Health Benefits and Chemical Composition of Matcha Green Tea: A Review |
| - | Review, | Nor, | NA |
| 6824- | EMD, | Neuroprotective, Anti-Inflammatory and Antifibrillogenic Offerings by Emodin against Alzheimer’s Dementia: A Systematic Review |
| - | Review, | AD, | NA |
| 6816- | EMD, | Emodin attenuates Alzheimer's disease by activating the protein kinase C signaling pathway |
| - | in-vivo, | AD, | NA |
| 6817- | EMD, | Emodin inhibits aggregation of amyloid-β peptide 1–42 and improves cognitive deficits in Alzheimer's disease transgenic mice |
| - | in-vivo, | AD, | NA |
| 6822- | EMD, | Behavioral, Histopathological, and Biochemical Implications of Aloe Emodin in Copper-Aβ-Induced Alzheimer's Disease-like Model Rats |
| - | in-vivo, | AD, | NA |
| 6574- | EU, | Effects of Eurycoma longifolia Jack on chronic cerebral hypoperfusion-induced oxidative damage and memory deficit in rats |
| - | in-vivo, | Nor, | NA |
| 3985- | Ex, | The combined effect of physical activity and fruit and vegetable intake on decreasing cognitive decline in older Taiwanese adults |
| - | Study, | AD, | NA |
| 4140- | Ex, | Experimental and clinical evidence of physical exercise on BDNF and cognitive function: A comprehensive review from molecular basis to therapy |
| - | Review, | AD, | NA |
| 4174- | Ex, | Exercise-Mediated Neurogenesis in the Hippocampus via BDNF |
| - | Review, | NA, | NA |
| 4137- | Ex, | The impact of exercise on patients with dementia |
| - | Trial, | AD, | NA |
| 4138- | Ex, | Relationship Between Exercise and Alzheimer’s Disease: A Narrative Literature Review |
| - | Review, | AD, | NA |
| 4139- | Ex, | Impact of physical exercise on the regulation of brain-derived neurotrophic factor in people with neurodegenerative diseases |
| - | Review, | AD, | NA |
| 4142- | Ex, | Mechanisms of the Beneficial Effects of Exercise on Brain-Derived Neurotrophic Factor Expression in Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4144- | Ex, | Exploring the impact of exercise-induced BDNF on neuroplasticity in neurodegenerative and neuropsychiatric conditions |
| - | Review, | AD, | NA |
| 2153- | Ex, | The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects |
| - | Review, | Var, | NA |
| 4073- | FA, | The importance of folic acid deficiency in the pathogenesis of vascular, mixed and Alzheimer's disease dementia |
| - | Study, | AD, | NA |
| 4070- | FA, | Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial |
| - | Trial, | AD, | NA |
| 4071- | FA, | Folate and Alzheimer: when time matters |
| - | Review, | AD, | NA |
| 4072- | FA, | Folic acid with or without vitamin B12 for cognition and dementia |
| - | Review, | AD, | NA |
| 4064- | FA, | VitB6, | VitB12, | High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial |
| - | Trial, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:557 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid